Skip to content
★ Sign in to follow
MR
Total declarations
15
Company
1
▲ Purchases (1 ops.)
€28k
▼ Sales (0 ops.)
—

Latest filing published 20 May 2021 for Xenon Pharmaceuticals Inc., €9,131.

Filing timeline

BuySale
Michael R. Hayden

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Michael R. Hayden: trading record in brief

This profile gathers the share dealings of Michael R. Hayden in Xenon Pharmaceuticals Inc. We count 15 filings; the first trade dates from 25 May 2016 and the latest from 18 May 2021.

No open-market sale appears; the market trades are 1 purchase worth €28k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 12 option exercises.

The latest filing, published on 20 May 2021, reports an option exercise of €9,131 in Xenon Pharmaceuticals Inc. The most recent open-market purchase was published on 14 August 2017, 3,374 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael R. Hayden

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations